Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he plans to introduce cannabis treatment on the NHS for people with Dravet Syndrome.
The licensed cannabis-based medicine Epidyolex is prescribed and routinely funded by the National Health Service for people with Dravet syndrome, Lennox-Gastaut syndrome and tuberous sclerosis complex. This follows approval by the Medicines and Healthcare products Regulatory Agency and assessment by the National Institute for Health and Care Excellence.